Kenvue Inc. (KVUE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kenvue Inc. (KVUE) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($294.00 Million) by net assets ($10.63 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KVUE net asset quality index to measure how much of total assets are equity-financed.
Kenvue Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Kenvue Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Kenvue Inc. to evaluate the quality of earnings relative to operating cash generation.
Kenvue Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kenvue Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Teck Resources Limited
TO:TECK-B
|
0.038x |
|
Gold Fields Limited
F:EDG
|
0.048x |
|
Transurban Group
AU:TCL
|
0.108x |
|
SANDVIK AB SP.ADR
F:SVK
|
0.046x |
|
Crown Castle
NYSE:CCI
|
-1.870x |
|
adidas AG
F:ADS
|
-0.055x |
|
China Pacific Insurance Group Co Ltd
SHG:601601
|
0.216x |
|
Orix Corp Ads
F:OIXA
|
0.068x |
Annual Cash Flow Conversion Efficiency for Kenvue Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Kenvue Inc. from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Kenvue Inc..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $9.67 Billion | $1.77 Billion | 0.183x | -35.25% |
| 2023-12-31 | $11.21 Billion | $3.17 Billion | 0.283x | +123.49% |
| 2022-12-31 | $19.97 Billion | $2.52 Billion | 0.126x | +672.23% |
| 2021-12-31 | $20.40 Billion | $334.00 Million | 0.016x | -91.15% |
| 2020-12-31 | $18.36 Billion | $3.40 Billion | 0.185x | -- |
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, … Read more